Establishment of Dissolution Specifications for Generic Drugs in Korea Pharmaceutical Codex Monograph - Nicametate Citrate Tablet, Norfloxacin Capsule
![]() |
Kim, Hee-Yun
(Hazardous Substances Analysis Division, Seoul Regional Korea Food and Drug Administration)
Choi, Seon-Hee (Hazardous Substances Analysis Division, Seoul Regional Korea Food and Drug Administration) Bang, Su-Jin (Hazardous Substances Analysis Division, Seoul Regional Korea Food and Drug Administration) Han, Kyung-Jin (Hazardous Substances Analysis Division, Seoul Regional Korea Food and Drug Administration) Choi, Sung-Hee (Hazardous Substances Analysis Division, Seoul Regional Korea Food and Drug Administration) Baek, Ji-Yun (Hazardous Substances Analysis Division, Seoul Regional Korea Food and Drug Administration) Kim, Dong-Sup (National Institute of Food and Drug Safety Evaluation, Pharmaceuticals and Medical Devices Research Department) Kim, Young-Ok (National Institute of Food and Drug Safety Evaluation, Scientific Drug Evaluation and Research Division) Sohn, Kyung-Hee (National Institute of Food and Drug Safety Evaluation, Scientific Drug Evaluation and Research Division) Song, Young-Me (Korea Food & Drug Administration, Bioequivalence Evaluation Division) Sah, Hong-Kee (College of Pharmacy, Ewha Womans University) Choi, Hoo-Kyun (College of Pharmacy, Chosun University) |
1 | EMEA, Active Substance Master File Procedure (2006). |
2 | EMEA, Investigation of Chiral Active Substance (1992). |
3 | EMEA, Summary of Requirements for Active Substance in Quality Part of the Dossier (2003). |
4 | EMEA, Chemistry of New Active Substance (2009). |
5 | 식품의약품안전청 : 대한약전 제9개정 (2007). |
6 | ICH, ICHQ6A "Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances" (1999). |
7 | The Japanese Pharmacopoeia 15th, Society of Japanese Pharmacopoeia (2006). |
8 | European Pharmacopoeia 6. (2008). |
9 | FDA, Guidance for Industry Drug Substance Chemistry, Manufacturing, and Controls Information (2004). |
10 | ICH, ICH Q8 "Pharmaceutical development" (2004). |
11 | 식품의약품안전청 : 경구용의약품의 용출규격 설정 가이드라인(2005). |
12 | EMEA, Specifications and Control Tests on the Finished Product (1991). |
13 | British Pharmacopoeia 2008, Medicines Commission London (2008). |
14 | 식품의약품안전청 : 대한약전외의약품등기준 제3개정 (2007). |
15 | The United States Pharmacopoeia 32, United States Pharmacopoeial Convention, Inc. (2009). |
16 | 식품의약품안전청 : 의약품동등성시험관리규정 (2009). |
17 | 식품의약품안전청 : 의약품등의 품목허가.신고.심사 규정 (2009). |
18 | 식품의약품안전청 : 의약품 등 시험방법 밸리데이션에 대한 가이드라인 적용을 위한 해설서. |
19 | 이종기 : 노르플록사신의 체내동태에 대한 신장해의 영향. 약제학회지 25(3), 265 (1995). |
![]() |